106 Additional Definitions Sample Clauses

The '106 Additional Definitions' clause serves to provide specific meanings for terms used throughout the contract that are not already defined elsewhere. This clause typically lists and clarifies the interpretation of particular words or phrases, ensuring that all parties have a shared understanding of key terminology. By establishing clear definitions, the clause helps prevent ambiguity and misunderstandings, thereby promoting consistency and reducing the risk of disputes over interpretation.
106 Additional Definitions. The following terms have the meanings set forth in the corresponding Sections of this Agreement: “AAA” 10.6.1
View SourceView Similar (7)
106 Additional Definitions. The following terms have the meanings set forth in the corresponding Sections of this Agreement: “Acceleron Indemnitees” 12.7.1
View SourceView Similar (3)
106 Additional Definitions. Each of the following definitions is set forth in the section of this Agreement indicated below: Actual Kolltan Development Costs 5.4.4 Auction License Agreement 5.4.3(e)(ii) 9.1 Auditing Party 6.9.1 Bankruptcy Code 2.4 Buyout Amount 5.4.1(b) Clinical and Research Supply Agreement 3.6.3(a) Co-Development and Co-Commercialization Agreement 5.4.1(c) Co-Development and Co-Commercialization Agreement Terms 5.4.1(c) Commercial Supply Agreement 3.6.4(a) Confidential Information 8.1 Court 12.2 Disclosing Party 8.1 Dispute 12.1 Effective Date Preamble Election Notice 5.4.1 Estimated Kolltan Development Costs 5.4.4 Exercise Notice 5.3.1(a) Existing Confidentiality Agreement 8.4 Expert 5.2.2(a) Final Kolltan Development Costs 5.4.4 Follow-On Product Transaction 2.5 Kolltan Preamble Kolltan ROFN Notice 2.5 Indemnified Party 10.3 Indemnifying Party 10.3 Indirect Taxes 6.9.3 Information Delivery Period 5.2.2(a) Inventory 3.6.1 Losses 10.1 Materials 3.6.1 MedImmune Preamble MedImmune ROFN Notice 2.5 Non-Paying Party 6.9.2 Option Period 5.3.1(a) Option Termination Date 3.5.2(a) Panel 5.2.2(a) Party or Parties Preamble Paying Party 6.9.1 Paying Party Withholding Tax Action 6.9.1 Product Acquisition Price Notice 5.2.2(b) Receiving Party 8.1 Resolution Period 12.1 Same or Later Stage Clinical Trial 12.4.2(a)(i) Selection Period 5.2.2(a) Sublicensed Rights 11.7.6 Third Party Transaction 5.5 Triggering Sale 12.4.2(a)(i) Trigger Period 5.2.1(a) Trigger Notice 5.2.1(a) Upfront Fee 6.1
View SourceView Similar (3)
106 Additional Definitions. The following terms have the meanings set forth in the corresponding Sections of this Agreement: “Acceleron Indemnitees” 12.7.1 “Acceleron NA Operating Costs” 5.5.3(b) “Acquired Party Activity” 6.3 “Audited Party” 5.7.4(b) “Auditing Party” 5.7.4(b) “Breaching Party” 11.2.1(a) “Celgene Indemnitees” 12.7.2 “Commercialization Plan/Budget” 2.5 “Defending Party” 8.4.3 “Forfeited Option Compound” 6.1.1 “Indemnitee” 12.7.3 “Infringement Claim” 8.4.1 “IP” 11.8 “JCC Chairperson” 3.2.3 “JDC Chairperson” 3.1.3 “Joint Development Committee” 3.1.1
View Source

Related to 106 Additional Definitions

  • Additional Definitions The following terms have the meanings given below:

  • Additional Definition Section 1.02 of the Credit Agreement is hereby amended to add thereto in alphabetical order the following definition which shall read in full as follows:

  • Additional Defined Terms As used herein, the following defined terms shall have the following meanings with respect to the Notes only:

  • Special Definitions For purposes of this Section, the following specialized terms will have the following meanings:

  • UCC Definitions Unless otherwise defined herein or the context otherwise requires, terms for which meanings are provided in the UCC are used in this Security Agreement, including its preamble and recitals, with such meanings.